Maimann Fysioterapi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 29.0% 8.7% 13.2%  
Credit score (0-100)  0 0 3 28 16  
Credit rating  N/A N/A B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 0.5 331  
EBITDA  0.0 0.0 0.0 0.1 -66.2  
EBIT  0.0 0.0 0.0 0.0 -99.6  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 -100.9  
Net earnings  0.0 0.0 0.0 0.0 -79.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 -101  

 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 0.2 103  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 0.3 143  

Net Debt  0.0 0.0 0.0 -0.1 -96.9  
 
See the entire balance sheet

Volume 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.5 331  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 68,957.9%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 143  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 46,801.0%  
Added value  0.0 0.0 0.0 0.0 -66.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 -0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 -1.0  

Profitability 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 9.2% -30.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 14.4% -138.9%  
ROI %  0.0% 0.0% 0.0% 22.3% -193.2%  
ROE %  0.0% 0.0% 0.0% 17.0% -153.6%  

Solidity 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  0.0% 0.0% 0.0% 59.7% 71.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -190.9% 146.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  0.0 0.0 0.0 2.2 2.7  
Current Ratio  0.0 0.0 0.0 2.2 2.7  
Cash and cash equivalent  0.0 0.0 0.0 0.1 96.9  

Capital use efficiency 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 0.1 69.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -66  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -66  
EBIT / employee  0 0 0 0 -100  
Net earnings / employee  0 0 0 0 -79